Related Experiment Video
Updated: May 11, 2026
05:18
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
Novel nonsurgical left ventricular assist device and system
Juna Misiri1, Christopher V DeSimone, Soon J Park
1Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Summary
Researchers developed a novel percutaneous left ventricular assist device (LVAD) system. This new approach bypasses the left ventricle, potentially reducing risks associated with traditional LVAD surgery for heart failure patients.
Area of Science:
- Cardiovascular Surgery
- Biomedical Engineering
- Medical Devices
Background:
- Advanced congestive heart failure treatment options are limited.
- Left ventricular assist devices (LVADs) support circulation but involve significant surgical risks.
- Current LVADs require invasive open-chest procedures.
Purpose of the Study:
- To introduce a novel percutaneous LVAD system.
- To evaluate a new device placement strategy bypassing the left ventricle.
- To minimize complications associated with traditional LVAD implantation.
Main Methods:
- Designed and developed an expandable nitinol device.
- Utilized aorto-left atrial continuity for device placement.
- Created a conduit for a percutaneous LVAD system.
Main Results:
- The aorto-left atrial continuity site is accessible and feasible for device placement.
- The novel approach creates a shunt between the left atrium and aorta.
- Experiments support the viability of this percutaneous LVAD accommodation.
Conclusions:
- A novel percutaneous LVAD system can be accommodated at the aorto-left atrial continuity.
- This approach bypasses the left ventricle, potentially reducing surgical morbidity.
- This innovative strategy offers a less invasive alternative for heart failure support.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.